Clinical Study for AL-CM

NCT04924998 · clinicaltrials.gov ↗

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Immunoglobulin Light Amyloidosis Cardiomyopathy

Interventions

DRUG: current treatment of AL-CM

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University